E/E′ ratio

There are 118 papers on E/E′ ratio in aging research: 16 trials and 80 observational studies in people, 11 in animals, 11 reviews. The newest story, Nov 13, 2026: “Lowering a protein improved heart relaxation in aged mice”.

Biomarker

118 papers study it12 more mention it33 findings

39 new papers in 30 daysSee all 130 papers on E/E′ ratio

“the change in standing time was correlated with the change in the early diastolic flow velocity / lateral mitral annular velocity (E/e') ratio (r = 0.28, P = 0.048).”
Effects of Reducing Sedentary Behaviour on Cardiac Structure and Function at Rest and During Exercise: A 6-Month Randomized Controlled TrialCJC open2025doi:10.1016/j.cjco.2025.09.005
  • Human trial16
  • Humans80
  • Animals11

Interventions

8

Dapagliflozin

downin humans2

2 studies
  1. Dapagliflozin decreases E/E′ ratio in humans (−1.17 [95% CI (−1.84, −0.50)]).

    “The primary endpoint, E/e′ ratio change, significantly differed between groups.”

    Human trial12 weeksn = 98

    Dapagliflozin-induced integrated improvements in left ventricular diastole, endothelial function, and arterial load: a randomized clinical trial

    Cardiovascular diabetology

  2. Dapagliflozin decreases E/E′ ratio in humans (type 2 diabetes) (-1.17 (0.34)).

    “resulting in a significant between-group difference of - 1.17 (0.34; p = 0.001).”

    Human trialtype 2 diabetes10 mg daily vs glibenclamide 5 mg daily12 weeksn = 96

    Dapagliflozin-induced integrated improvements in left ventricular diastole, endothelial function, and arterial load: a randomized clinical trial

    Cardiovascular diabetology

  3. Dapagliflozin is linked with lower E/E′ ratio in humans (HFpEF; combined with standard guideline-directed therapy) (14.8 ± 3.2 to 12.1 ± 2.7).

    “E/e' ratio decreased significantly from 14.8 ± 3.2 to 12.1 ± 2.7 (P < 0.001)”

    HumansHFpEF; combined with standard guideline-directed therapyheart6 monthsn = 58

    SGLT-2 inhibitor dapagliflozin improves left ventricular diastolic function and reduces circulating inflammatory markers in HFpEF patients: a retrospective cohort study

    American journal of translational research

More on Dapagliflozin

Inspiratory muscle training

downin humans1

1 study
  1. Inspiratory muscle training decreases E/E′ ratio in humans (Median E/E′ 10.9 versus 15.5; p = 0.059).

    “At 5 months, the IMT group demonstrated a favourable shift in diastolic function (median E/E′ 10.9 vs 15.5; p = 0.059).”

    Human trialStable chronic heart failure; added to standard cardiac rehabilitation versus standard cardiac rehabilitation alonehome-based training using a threshold deviceheart30% of maximal inspiratory pressure5 monthsn = 40

    Effects of inspiratory muscle training for urban patients with chronic heart failure: a randomized controlled trial

    ESC Congress 2026 abstract

More on Inspiratory muscle training

Exenatide

downin humans1

1 study
  1. Exenatide decreases E/E′ ratio in humans (patients with obesity) (MD −2.64; 95% CI −4.48 to −0.81).

    “a reduction in E/e’ ratio (MD −2.64; 95% CI −4.48 to −0.81)”

    Reviewpatients with obesityheart1 year

    Effects of glucagon-like peptide 1 receptor agonists versus bariatric surgeries on cardiac function improvement: a network meta-analysis

    ESC Congress 2026 abstract

More on Exenatide

Tirzepatide

downin humans1

1 study
  1. Tirzepatide is linked with lower E/E′ ratio in humans (obesity-related HFpEF, prospective real-world cohort) (-1.45 (95% CI -1.85 to -1.11)).

    “E/e' improved by -1.45 (95% CI -1.85 to -1.11; q < 0.001; SRM -1.08)”

    Humansobesity-related HFpEF, prospective real-world cohortleft ventriclemedian follow-up 5.8 monthsn = 50

    Association of tirzepatide with reverse cardiac remodeling and improved diastolic function in obesity-related HFpEF: A prospective real-world cohort study

    International journal of cardiology

More on Tirzepatide

Resveratrol

downin humans1

1 study
  1. Resveratrol decreases E/E′ ratio in addition to conventional therapy.

    “After 6 months, the RES group had smaller left atrial, lower E/e', higher left ventricular global longitudinal strain”

    Human trialin addition to conventional therapyleft ventricle400 mg/d6 months

    Effects of resveratrol supplementation on cardiac remodeling in hypertensive patients: a randomized controlled clinical trial

    Hypertension research : official journal of the Japanese Society of Hypertension

More on Resveratrol

Leg-positive pressure maneuver

upin humans1

1 study
  1. Leg-positive pressure maneuver is linked with higher E/E′ ratio in humans (middle-aged, elderly and HFpEF subjects) (16 ± 5 to 17 ± 7 in HFpEF).

    “During LPP stress, the E/e' ratio significantly increased in the middle-aged and elderly groups (from 8 ± 2 to 9 ± 3, from 10 ± 2 to 12 ± 3, P < 0.05, respectively), and this was more pronounced in patients with HFpEF”

    Humansmiddle-aged, elderly and HFpEF subjectsheart

    "Accelerated aging" of the heart as heart failure with preserved ejection fraction-analysis using leg-positive pressure stress echocardiography

    The international journal of cardiovascular imaging

More on Leg-positive pressure maneuver

Tofogliflozin

downin humans1

1 study
  1. Tofogliflozin is linked with lower E/E′ ratio in elderly patients with type 2 diabetes.

    “E/A, E/e' and LAD significantly decreased”

    Humansin elderly patients with type 2 diabetesleft ventricle20 mg daily1 month

    Effects of Tofogliflozin on Cardiac Function in Elderly Patients With Diabetes Mellitus

    Journal of clinical medicine research

More on Tofogliflozin

Air pollution

no changein humans1

1 study
  1. Air pollution was not clearly linked with E/E′ ratio in humans (preserved ejection fraction).

    “None of the pollutants were clearly associated with E/E'.”

    Humanspreserved ejection fractionheartfemalesn = 264

    Air pollution and diastolic function in elderly women - Results from the SALIA study cohort

    International journal of hygiene and environmental health

More on Air pollution

Upstream

3

Low LE8 and high PRS for LVMI

upin humans1

1 study
  1. low LE8 and high PRS for LVMI is linked with higher E/E′ ratio in humans (compared to high LE8+low PRS referent group).

    “individuals in the low LE8-high PRS group had high LVMI, E/e', and over three-fold higher risks for CVD and CHD”

    Humanscompared to high LE8+low PRS referent group56% womens

    Association of Cardiovascular Health and Genetic Risk for Left Ventricular Mass with Left Ventricular Structure, Function, and Incident Cardiovascular Outcomes

    medRxiv : the preprint server for health sciencesPreprint

Age

upin humans1

1 study
  1. Age is linked with higher E/E′ ratio in humans (healthy controls) (ANOVA, P < 0.001).

    “With an increase in age, progressive concentric left ventricular (LV) remodeling was observed in healthy controls, resulting in the hemodynamic consequences of an age-dependent increase in the E/e' ratio”

    Humanshealthy controlsheartn = 77

    "Accelerated aging" of the heart as heart failure with preserved ejection fraction-analysis using leg-positive pressure stress echocardiography

    The international journal of cardiovascular imaging

South Asian ethnicity

upin humans1

1 study
  1. South Asian ethnicity is linked with higher E/E′ ratio in humans (compared to Afro-Caribbeans).

    “SAs had significantly accelerated age-dependent increase in E/e' compared to ACs.”

    Humanscompared to Afro-Caribbeansn = 4,540

    Premature Cardiac Aging in South Asian Compared to Afro-Caribbean Subjects in a Community-Based Screening Study

    Journal of the American Heart Association

Associations

20

Peak oxygen saturation

downin humans1OR 0.97

1 study
  1. E/E′ ratio is associated with peak oxygen saturation in humans (OR 0.97, 95% CI 0.95–0.99; p = 0.003 before additional BMI and hsCRP adjustment).

    “Individuals with an elevated E/e’ ratio was also more likely to have lower OxyP levels than those with a normal E/e’ ratio”

    HumansElevated versus normal E/e’ ratio; adjusted for age, sex and current smoking; association no longer significant after adding BMI and hsCRPskinn = 3,809

    Impaired skin microvascular function and prevalent coronary atherosclerosis and cardiac function in a general population

    Scientific reports

More on Peak oxygen saturation

SGLT2 inhibitors

downin humans1

1 study
  1. SGLT2 inhibitors are associated with E/E′ ratio in humans (patients with hypertrophic cardiomyopathy) (MD -4.39, 95% CI -5.50 to -3.28).

    “SGLT2i therapy was associated with a reduction in E/e′ ratio”

    Reviewpatients with hypertrophic cardiomyopathyleft ventriclen = 236

    SGLT2 Inhibitors as a Novel Therapeutic Strategy for Diastolic Improvement and Survival in Hypertrophic Cardiomyopathy

    AHA Scientific Sessions 2026 abstract

More on SGLT2 inhibitors

Physical activity

downin humans1

1 study
  1. Physical activity is associated with E/E′ ratio in humans (Age-and-sex-adjusted association) (r=-0.230 to -0.283; all p<0.001; R2=0.320).

    “Higher step activity was associated with lower E/e' ratio”

    HumansAge-and-sex-adjusted associationheartFirst 6 months post-enrollment55% femalesn = 2,333

    Wearable-Derived Step Activity Associates with Echocardiographic Diastolic Function Measures and Reveals a Sex-Specific Interaction in the Project Baseline Health Study

    AHA Scientific Sessions 2026 abstract

More on Physical activity

Fibrosis-4 score

upin humans1

1 study
  1. Fibrosis-4 score is associated with E/E′ ratio in humans (MASLD; adjusted for age, sex, and the number of metabolic syndrome components).

    “the FIB-4 index remained a significant independent predictor of the E/e’ ratio even after adjusting for age, sex, and the number of metabolic syndrome components.”

    HumansMASLD; adjusted for age, sex, and the number of metabolic syndrome componentsheart17.4% femalesn = 2,349

    Fibrosis-4 (FIB-4) score is associated with early diastolic dysfunction in metabolic dysfunction-associated steatotic liver disease (MASLD)

    ESC Congress 2026 abstract

More on Fibrosis-4 score

Renal resistive index

upin humans1

1 study
  1. Renal resistive index is associated with E/E′ ratio in humans (r = 0.440, p < 0.001).

    “RRI correlated positively with E/e', linking higher renal vascular resistance with higher estimated LV filling pressure (r = 0.440, p < 0.001).”

    Humans

    Cardio-renal dysfunction in prediabetes and early type 2 diabetes: insights from myocardial strain and renal Doppler assessment

    BMC cardiovascular disorders

More on Renal resistive index

White matter hyperintensities

upin humans1+7.9% increase

1 study
  1. E/E′ ratio is associated with white matter hyperintensities in humans (7.9% increase).

    “E/eʹ ratio (7.9% increase, p = 0.017)”

    Humansfrontal lobe5–7 yearsn = 445

    Associations of Echocardiographic Biomarkers with White Matter Hyperintensities: Insights from the British 1946 Birth Cohort

    AAIC 2025 abstract

More on White matter hyperintensities

Visceral adipose tissue area

upin humans1

1 study
  1. Visceral adipose tissue area is associated with E/E′ ratio in humans (South Asians with higher VAT than BMI).

    “Those with higher VAT than BMI had evidence of increase LV filling pressures with higher E/e’ ratio at rest and with legs up.”

    HumansSouth Asians with higher VAT than BMIn = 675

    Adiposity and Cardiac Function in South Asian Americans: Findings from the MASALA Study

    AHA Scientific Sessions 2025 abstract

More on Visceral adipose tissue area

Ozone

upin humans1

1 study
  1. Ozone is associated with E/E′ ratio in humans (0.47 increase per ppb (95% CI: 0.06-0.88)).

    “each part per billion increase in O3 exposure was associated with a 0.47 increase in E/STe' ratio (95% CI: 0.06-0.88)”

    Humans

    Cross-Sectional Association of Ground-Level Ozone and Nitrogen Dioxide With Cardiac Mechanics Using Speckle-Tracking Echocardiography in the Cardiovascular Health Study

    Echocardiography (Mount Kisco, N.Y.)

More on Ozone

Standing

upin humans1

1 study
  1. Standing is associated with E/E′ ratio in humans (r = 0.28, P = 0.048).

    “the change in standing time was correlated with the change in the early diastolic flow velocity / lateral mitral annular velocity (E/e') ratio (r = 0.28, P = 0.048).”

    Human trial6 months

    Effects of Reducing Sedentary Behaviour on Cardiac Structure and Function at Rest and During Exercise: A 6-Month Randomized Controlled Trial

    CJC open

More on Standing

Frailty index

upin humans1

1 study
  1. Frailty index is associated with E/E′ ratio in humans (elderly cancer patients).

    “the Frailty index showed a direct correlation with the E/e' ratio (p = 0.005)”

    Humanselderly cancer patientsheartn = 62

    Cardio-Oncology Challenges in Elderly Patients

    Journal of clinical medicine

More on Frailty index

All 20

Latest

Dec 2025: 2Jan 2026: 6Feb 2026: 2Mar 2026: 8Apr 2026: 1May 2026: 0Jun 2026: 3Jul 2026: 2Aug 2026: 4Sep 2026: 5Oct 2026: 26Nov 2026: 1473 papers in 12 months
Cell Biology and Toxicology

Lowering a protein improved heart relaxation in aged mice

Mice given a heart-cell-targeted gene-silencing injection at 90 weeks had less inflammation and better heart relaxation when assessed at 110 weeks.Mice given a heart-cell-targeted gene-silencing injection at 90 weeks had less inflammation and better heart relaxation when assessed at 110 weeks.

Mouse studyMechanisms
AHA Scientific Sessions 2026 Abstract

Heart tracing model identifies patients at higher death risk

Five-year mortality was 29.8% in the model’s highest filling-pressure category versus 14.2% in its lowest among patients with grade 1 heart relaxation abnormalities.Five-year mortality was 29.8% in the model’s highest filling-pressure category versus 14.2% in its lowest among patients with grade 1 heart relaxation abnormalities.

Cohort · 18,243 peopleBiomarkers

See all 130 papers on E/E′ ratio